 CAMBRIDGE, Mass., Sept. 01, 2021 GLOBE NEWSWIRE -- Praxis Precision Medicines, Inc. NASDAQ: PRAX, a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system CNS disorders characterized by neuronal imbalance, today announced that management will participate in the Emerging Therapies for Psychiatric Disorders panel at Citis 16th Annual BioPharma Virtual Conference on Wednesday, September 8, 2021 at 10:40 a.m. ET. 